To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene HIP1RTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
278 supporting clones for gene HIP1R back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BX366385 Neuroblastoma Cot 25-normalized .a 1 to 665 1 to 663   tiling clone,   518/663
(78 %)
31 diff
(95.4 %id)
BG106639 lymph, lymphoma, cell line .a 18 to 304 1 to 287   tiling clone,   287/287
(100 %)
1 diff
(99.7 %id)
BQ688086 ductal carcinoma, cell line, Pancreas .a 30 to 898 1 to 876       876/896
(97 %)
15 diff
(98.4 %id)
NM_003959.1   .a 30 to 4502 1 to 4473 exact RefSeq,   4473/4473
(100 %)
2 diff
(100.0 %id)
BM548328 brain, hippocampus .a 38 to 798 21 to 786       766/1095
(69 %)
31 diff
(97.2 %id)
AB014555 brain .a 42 to 4502 1 to 4457 exact tiling clone, available from KIAA,   4457/4457
(100 %)
5 diff
(99.9 %id)
BM926334 brain .a 50 to 945 20 to 917       898/1048
(85 %)
26 diff
(97.6 %id)
DA251013 caudate nucleus .a 67 to 634 2 to 569   capped   568/568
(100 %)
2 diff
(99.7 %id)
DN999302   .a 76 to 748 1 to 674       674/674
(100 %)
11 diff
(98.4 %id)
AL119481 amygdala .a 91 to 385 1 to 306       306/311
(98 %)
23 diff
(92.7 %id)
BI597177 brain, hypothalamus .a 96 to 945 7 to 858       852/923
(92 %)
25 diff
(97.3 %id)
TI_45215536   .a 96 to 945 95 to 946       852/1011
(84 %)
25 diff
(97.6 %id)
DB498639 hypothalamus .a 98 to 595 1 to 499       499/499
(100 %)
4 diff
(99.2 %id)
DB503856 hypothalamus .a 98 to 575 1 to 478       478/478
(100 %)
2 diff
(99.6 %id)
CN431300 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 139 to 776 1 to 638       638/638
(100 %)
3 diff
(99.6 %id)
BG910345 anaplastic oligodendroglioma with 1p/19qloss, brain .a 244 to 304 1 to 61       61/61
(100 %)
3 diff
(95.1 %id)
BG910408 anaplastic oligodendroglioma with 1p/19qloss, brain .a 246 to 304 1 to 60       60/60
(100 %)
2 diff
(96.7 %id)
AI910277 breast .a 544 to 865 11 to 332       322/332
(96 %)
12 diff
(96.4 %id)
AW504715 lymph .a 568 to 986 1 to 419       419/419
(100 %)
5 diff
(98.9 %id)
TI_154160984   .a 574 to 1188 69 to 682       614/737
(83 %)
24 diff
(96.8 %id)
BF853683 lung_normal .a 584 to 945 1 to 362       362/367
(98 %)
7 diff
(98.1 %id)
AB013384 neuroblastoma .a 623 to 4502 1 to 3876       3876/3876
(100 %)
4 diff
(99.9 %id)
BG569566 Liver .a 639 to 1338 1 to 701       701/715
(98 %)
4 diff
(99.5 %id)
BE935079 marrow .a 664 to 953 306 to 4       303/319
(94 %)
22 diff
(93.2 %id)
BF347655 anaplastic oligodendroglioma with 1p/19qloss, brain .a 665 to 1197 23 to 555       533/787
(67 %)
11 diff
(98.7 %id)
AW504218 lymph .a 823 to 1264 1 to 442       442/442
(100 %)
5 diff
(98.9 %id)
TI_154160359   .a 830 to 1377 83 to 628       546/548
(99 %)
11 diff
(98.0 %id)
BQ440520 melanotic melanoma, skin .a 937 to 1706 1 to 786       782/957
(81 %)
24 diff
(97.5 %id)
BF527206 anaplastic oligodendroglioma with 1p/19qloss, brain .a 1168 to 1828 1 to 673       673/673
(100 %)
23 diff
(96.6 %id)
BF530760 anaplastic oligodendroglioma with 1p/19qloss, brain .a 1295 to 2023 1 to 726       726/790
(91 %)
11 diff
(98.7 %id)
BG819121 anaplastic oligodendroglioma with 1p/19qloss, brain .a 1316 to 1902 1 to 610       583/876
(66 %)
33 diff
(96.3 %id)
BI772606 pooled lung and spleen .a 1330 to 2049 27 to 750       724/750
(96 %)
29 diff
(96.2 %id)
TI_57178861   .a 1330 to 2049 27 to 750       724/750
(96 %)
29 diff
(96.2 %id)
BG818838 anaplastic oligodendroglioma with 1p/19qloss, brain .a 1521 to 2229 1 to 708       708/708
(100 %)
5 diff
(99.3 %id)
CT003128 T-Lymphocytes .a 1544 to 2421 1 to 880       880/881
(99 %)
8 diff
(99.1 %id)
AL120410 amygdala .a 1632 to 2124 1 to 493       493/493
(100 %)
0 diff
(100 %id)
AL120508 amygdala .a 1632 to 1929 1 to 298       298/298
(100 %)
3 diff
(99.0 %id)
BQ719921 sympathetic trunk .a 1688 to 2285 5 to 605       601/917
(65 %)
17 diff
(98.2 %id)
CD580482 brain .a 1700 to 2541 1 to 843       843/913
(92 %)
17 diff
(98.2 %id)
BC038981 Brain, Lung, Testis, adult, pooled whole .a 1895 to 4495 169 to 2765   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 2597/2765
(93 %)
12 diff
(99.6 %id)
BM921269 pooled brain, lung, testis .a 1895 to 2429 175 to 711       537/1105
(48 %)
18 diff
(98.4 %id)
CU451369 epidermis .a 1903 to 2522 22 to 641       620/641
(96 %)
8 diff
(98.8 %id)
BG819953 anaplastic oligodendroglioma with 1p/19qloss, brain .a 1921 to 2523 1 to 614       614/619
(99 %)
26 diff
(95.8 %id)
CA488778   .a 2031 to 2858 1 to 842       842/902
(93 %)
21 diff
(97.7 %id)
BI919025 brain .a 2057 to 2610 1 to 563       563/563
(100 %)
20 diff
(96.5 %id)
BM926946 brain .a 2057 to 2855 20 to 820       801/1050
(76 %)
22 diff
(98.0 %id)
TI_57240721   .a 2057 to 2610 1 to 563       563/563
(100 %)
20 diff
(96.5 %id)
DC346671 tongue, tumor tissue .a 2106 to 2665 1 to 560       560/560
(100 %)
0 diff
(100 %id)
DC368578   .a 2112 to 2675 1 to 565       565/565
(100 %)
1 diff
(99.9 %id)
BE244254 leukopheresis .a 2128 to 2552 425 to 1       425/425
(100 %)
7 diff
(98.4 %id)
BQ710016 Spleen .a 2186 to 2634 71 to 522       452/1318
(34 %)
9 diff
(99.4 %id)
CB153680 brain .a 2196 to 2653 85 to 542       458/542
(84 %)
6 diff
(98.9 %id)
AW402592 lymph .a 2278 to 2824 1 to 547       547/547
(100 %)
6 diff
(99.0 %id)
TI_154139025   .a 2285 to 3042 80 to 832       753/775
(97 %)
26 diff
(96.7 %id)
BX487084   .a 2315 to 2843 1 to 529       529/529
(100 %)
3 diff
(99.5 %id)
DC406070 thymus .a 2372 to 2889 1 to 518       518/518
(100 %)
1 diff
(99.9 %id)
BI013886 lung_tumor .a 2381 to 2827 18 to 466       449/467
(96 %)
8 diff
(98.3 %id)
DR761531 embryonic stem .a 2385 to 3124 1 to 740       740/740
(100 %)
2 diff
(99.8 %id)
AK024062   .a 2386 to 4495 1 to 2106   available from FLJ,   2106/2106
(100 %)
7 diff
(99.7 %id)
AU143644   .a 2387 to 3133 2 to 746   capped   745/745
(100 %)
8 diff
(99.0 %id)
BF345440 anaplastic oligodendroglioma with 1p/19qloss, brain .a 2389 to 3166 1 to 792       792/1118
(70 %)
14 diff
(98.8 %id)
BM152565 leukopheresis .a 2429 to 2552 126 to 1       126/133
(94 %)
6 diff
(95.5 %id)
AK295389 corpus callosum .a 2440 to 3532 1 to 1093       1093/1093
(100 %)
3 diff
(99.8 %id)
DC328727 corpus callosum .a 2440 to 2994 1 to 555       555/555
(100 %)
2 diff
(99.7 %id)
BF822632 kidney_tumor .a 2507 to 2709 23 to 224       202/243
(83 %)
14 diff
(94.3 %id)
CA487289   .a 2544 to 3426 1 to 891       891/894
(99 %)
27 diff
(97.0 %id)
BF347401 anaplastic oligodendroglioma with 1p/19qloss, brain .a 2547 to 3231 1 to 680       680/864
(78 %)
12 diff
(98.7 %id)
TI_151795525.
matches multiple genes
  .a 2587 to 3206 118 to 742     Possibly primed on the genome, locally A rich (23/24 A in genome downstream of last aligned base), also hits gene tuky 625/962
(64 %)
17 diff
(98.3 %id)
AW247539 lung, small cell carcinoma .a 2602 to 2845 9 to 252     Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 244/252
(96 %)
6 diff
(97.7 %id)
BF530165 anaplastic oligodendroglioma with 1p/19qloss, brain .a 2636 to 3216 6 to 597       592/757
(78 %)
31 diff
(96.0 %id)
CB216375 normal endometrium, mid-secretory phase,cycle day 23, uterus .a 2641 to 3246 1 to 606       606/606
(100 %)
1 diff
(99.9 %id)
BF855445 prostate_normal .a 2647 to 2869 1 to 222       222/222
(100 %)
2 diff
(99.1 %id)
DA363424 subthalamic nucleus .a 2666 to 3217 2 to 555   capped   554/554
(100 %)
3 diff
(99.5 %id)
CX871022 embryonic stem .a 2676 to 3495 6 to 825       820/825
(99 %)
14 diff
(98.4 %id)
BG754124 B-cells, primary B-cells from tonsils (cell line) .a 2685 to 3313 1 to 631       631/631
(100 %)
4 diff
(99.4 %id)
BG753892 B-cells, primary B-cells from tonsils (cell line) .a 2685 to 3381 1 to 697       697/697
(100 %)
3 diff
(99.6 %id)
BF128690 B-cells, primary B-cells from tonsils (cell line) .a 2705 to 3300 1 to 592       592/592
(100 %)
9 diff
(98.5 %id)
BF348082 anaplastic oligodendroglioma with 1p/19qloss, brain .a 2714 to 3479 1 to 754       754/938
(80 %)
17 diff
(98.2 %id)
BI333976 cervical carcinoma cell line, cervix .a 2732 to 3312 28 to 608       581/608
(95 %)
17 diff
(97.3 %id)
AI272228 brain, oligodendroglioma .a 2768 to 3036 1 to 269     Submitted on the opposite strand 269/270
(99 %)
3 diff
(98.9 %id)
DA517513 brain .a 2773 to 3274 2 to 503   capped   502/502
(100 %)
3 diff
(99.5 %id)
BI917453 brain .a 2791 to 3270 1 to 479       479/481
(99 %)
3 diff
(99.4 %id)
TI_57244821   .a 2791 to 3270 35 to 513       479/515
(93 %)
8 diff
(98.5 %id)
CD672992 eye, Iris .a 2888 to 3258 1 to 371       371/371
(100 %)
3 diff
(99.2 %id)
T33837 brain .a 2892 to 3264 1 to 372       372/372
(100 %)
5 diff
(98.7 %id)
T08283   .a 2895 to 3275 1 to 380       380/391
(97 %)
4 diff
(99.0 %id)
DA566357 heart .a 2918 to 3469 2 to 555   capped   554/554
(100 %)
4 diff
(99.3 %id)
BU539868 adenocarcinoma, cell line, breast .a 2918 to 3753 1 to 839       839/912
(91 %)
29 diff
(96.9 %id)
BG820246 anaplastic oligodendroglioma with 1p/19qloss, brain .a 2929 to 3708 1 to 789       789/789
(100 %)
15 diff
(98.1 %id)
BF337218 brain, glioblastoma with EGFR amplification .a 2933 to 3798 1 to 865   tiling clone,   865/1156
(74 %)
38 diff
(96.8 %id)
BE696603 colon .a 2937 to 3072 136 to 1       136/136
(100 %)
2 diff
(98.6 %id)
CB269212 adipose .a 2939 to 3445 1 to 506       506/506
(100 %)
2 diff
(99.7 %id)
BU558073 adenocarcinoma, cell line, breast .a 2944 to 3840 7 to 909       903/925
(97 %)
43 diff
(95.4 %id)
CF457389 peripheral nervous system .a 2950 to 3721 1 to 772       772/772
(100 %)
1 diff
(99.9 %id)
AA351038 brain .a 2970 to 3337 1 to 369       369/369
(100 %)
9 diff
(97.6 %id)
BM714747 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 2988 to 3560 1 to 573     Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 573/573
(100 %)
1 diff
(99.9 %id)
BQ711096 Spleen .a 3038 to 3936 1 to 909       909/922
(98 %)
32 diff
(96.6 %id)
BQ929527 leiomyosarcoma, uterus .a 3043 to 3912 1 to 884       884/948
(93 %)
20 diff
(97.9 %id)
EC560649 Prostate .a 3077 to 3171 1 to 96       96/96
(100 %)
1 diff
(99.0 %id)
BF929980 nervous_tumor .a 3084 to 3499 14 to 429       416/429
(96 %)
6 diff
(98.7 %id)
TI_57240391   .a 3115 to 3905 34 to 824       791/824
(95 %)
13 diff
(98.5 %id)
BI913204 brain .a 3121 to 3905 1 to 785       785/785
(100 %)
7 diff
(99.2 %id)
CD517444 White Matter .a 3153 to 3753 27 to 628       602/632
(95 %)
12 diff
(98.2 %id)
AA586536 bulk tumor, colon .a 3193 to 3305 27 to 139     Submitted on the opposite strand 113/139
(81 %)
6 diff
(95.7 %id)
R70178 breast .a 3238 to 3470 1 to 230       230/230
(100 %)
6 diff
(97.4 %id)
BE164136 head_neck .a 3243 to 3630 1 to 388       388/388
(100 %)
2 diff
(99.5 %id)
BE164139 head_neck .a 3244 to 3630 1 to 387       387/387
(100 %)
1 diff
(99.8 %id)
BE164423 head_neck .a 3244 to 3627 1 to 383       383/383
(100 %)
5 diff
(98.7 %id)
BE164138 head_neck .a 3245 to 3626 387 to 3     Submitted on the opposite strand 385/390
(98 %)
0 diff
(100 %id)
BF514308   .a 3385 to 3667 308 to 26   AAA   283/301
(94 %)
0 diff
(100 %id)
EC451926 Prostate .a 3422 to 3526 1 to 103       103/103
(100 %)
4 diff
(96.2 %id)
EC561987 Prostate .a 3453 to 3557 1 to 106       106/106
(100 %)
2 diff
(98.2 %id)
BX366384 Neuroblastoma Cot 25-normalized .a 3470 to 4481 1000 to 1       1000/1000
(100 %)
37 diff
(96.3 %id)
BF529105 anaplastic oligodendroglioma with 1p/19qloss, brain .a 3488 to 4307 1 to 800   tiling clone,   800/919
(87 %)
25 diff
(97.3 %id)
BE304650 adenocarcinoma cell line, colon .a 3492 to 4163 1 to 666       666/724
(91 %)
6 diff
(99.2 %id)
AA204665 germinal center B cell .a 3517 to 4036 1 to 521       521/521
(100 %)
12 diff
(97.7 %id)
CF454957 peripheral nervous system .a 3520 to 4116 47 to 640       594/797
(74 %)
31 diff
(96.2 %id)
AA737391 Ewing's sarcoma .a 3521 to 3677 1 to 155       155/155
(100 %)
7 diff
(95.5 %id)
AA282148 germinal center B cell .a 3526 to 3877 1 to 356     Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 356/359
(99 %)
6 diff
(98.4 %id)
EC447959 Prostate .a 3544 to 3654 1 to 111       111/111
(100 %)
0 diff
(100 %id)
BF357100 head_neck .a 3552 to 4150 25 to 616       592/616
(96 %)
6 diff
(99.1 %id)
EC528860 Prostate .a 3563 to 3681 1 to 118       118/118
(100 %)
1 diff
(99.2 %id)
BM711588 eye, human retina .a 3576 to 3922 1 to 342   fully sequenced, Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 342/342
(100 %)
2 diff
(99.5 %id)
EC480012 Prostate .a 3603 to 3710 1 to 106       106/106
(100 %)
3 diff
(97.2 %id)
AA491076.
matches multiple genes
germinal center B cell .a 3609 to 4083 1 to 467     also hits gene tuky 467/467
(100 %)
9 diff
(98.1 %id)
CN431301 embryonic stem cells, DMSO-treated H9 cellline .a 3611 to 4376 1 to 765       765/769
(99 %)
8 diff
(99.0 %id)
EC545982 Prostate .a 3612 to 3720 1 to 107       107/107
(100 %)
5 diff
(95.4 %id)
BM787352 Ascites, stomach .a 3614 to 4037 1 to 420       420/420
(100 %)
10 diff
(97.7 %id)
EC500528 Prostate .a 3616 to 3714 1 to 101       101/101
(100 %)
4 diff
(96.1 %id)
EC471604 Prostate .a 3619 to 3714 1 to 96       96/96
(100 %)
0 diff
(100 %id)
BM665505 eye, human retina .a 3892 to 4495 616 to 19   tiling clone, fully sequenced, AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 598/598
(100 %)
4 diff
(99.4 %id)
BU739377 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 4021 to 4495 493 to 19   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 475/475
(100 %)
1 diff
(99.8 %id)
AU160703   .a 4043 to 4495 453 to 1       453/453
(100 %)
3 diff
(99.4 %id)
AA282149 germinal center B cell .a 4215 to 4502 304 to 17   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 288/288
(100 %)
0 diff
(100 %id)
AW245145 lung, small cell carcinoma .a 4219 to 4502 294 to 11   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 284/284
(100 %)
0 diff
(100 %id)
AL119320 amygdala .b 1 to 738 61 to 806   tiling clone,   746/923
(80 %)
23 diff
(97.6 %id)
DN999807   .b 44 to 637 9 to 602       594/602
(98 %)
7 diff
(98.9 %id)
BM452528 lymph, lymphoma, cell line .b 79 to 937 1 to 865       865/983
(87 %)
14 diff
(98.6 %id)
AK298387 Kidney .b 97 to 2150 1 to 2054 Q174* tiling clone,   2054/2054
(100 %)
5 diff
(99.8 %id)
DC362480 Kidney .b 97 to 681 1 to 585       585/590
(99 %)
2 diff
(99.7 %id)
BC067085 Pancreas, ductal carcinoma .b 105 to 2095 1 to 1991 N345S tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 1991/1991
(100 %)
4 diff
(99.8 %id)
BU163645 ductal carcinoma, cell line, Pancreas .b 108 to 947 1 to 846       846/892
(94 %)
10 diff
(98.9 %id)
BQ692002 ductal carcinoma, cell line, Pancreas .b 108 to 942 1 to 836       836/875
(95 %)
6 diff
(99.4 %id)
BQ688927 ductal carcinoma, cell line, Pancreas .b 108 to 917 1 to 813       811/892
(90 %)
5 diff
(99.5 %id)
BM786529 Ascites, stomach .b 109 to 742 1 to 634       634/634
(100 %)
2 diff
(99.7 %id)
BX281085 brain .b 128 to 628 1 to 501       501/501
(100 %)
1 diff
(99.9 %id)
BX110172 anaplastic oligodendroglioma, brain .c 1 to 444 1 to 444   tiling clone,   444/444
(100 %)
1 diff
(99.8 %id)
DA790979 brain .c 47 to 601 2 to 557   tiling clone, capped   556/556
(100 %)
1 diff
(99.9 %id)
AW450311   .c 127 to 454 1 to 328   tiling clone, AAA Submitted on the opposite strand 328/331
(99 %)
3 diff
(99.1 %id)
AI356106 anaplastic oligodendroglioma, brain .c 157 to 466 334 to 25   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 310/334
(92 %)
0 diff
(100 %id)
AK090537   .c 296 to 2961 1 to 2666 exact tiling clone, available from FLJ,   2666/2666
(100 %)
4 diff
(99.9 %id)
DA019351   .c 297 to 848 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
DA052149   .c 297 to 892 2 to 597   capped   596/596
(100 %)
1 diff
(99.9 %id)
DA315021 hippocampus .c 297 to 837 2 to 542   capped   541/541
(100 %)
1 diff
(99.9 %id)
DA779723 brain .c 297 to 869 2 to 574   tiling clone, capped   573/573
(100 %)
0 diff
(100 %id)
DA797099 brain .c 297 to 858 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
CN411869 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 323 to 586 1 to 264       264/275
(96 %)
1 diff
(99.7 %id)
BM706487 eye, eye anterior segment .c 898 to 1408 9 to 519       511/519
(98 %)
7 diff
(98.7 %id)
BM673310 eye, eye anterior segment .c 1942 to 2390 467 to 19   AAA   449/449
(100 %)
2 diff
(99.6 %id)
BG990871 head_neck .c 2102 to 2432 347 to 15       333/347
(95 %)
0 diff
(100 %id)
BF739387 bladder_tumor .c 2201 to 2569 380 to 9     Submitted on the opposite strand 372/383
(97 %)
13 diff
(96.7 %id)
BM997354 lung, Metastatic Chondrosarcoma .c 2348 to 2911 580 to 19   AAA   562/564
(99 %)
5 diff
(99.2 %id)
DB295495   .c 2412 to 2961 550 to 1       550/551
(99 %)
1 diff
(99.9 %id)
BX957050   .c 2459 to 3078 1 to 620   tiling clone,   620/620
(100 %)
1 diff
(99.9 %id)
BQ188603 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 2477 to 2915 1 to 439   AAA   439/439
(100 %)
2 diff
(99.6 %id)
CD723548 eye, lacrimal gland .c 3018 to 3725 1 to 610   tiling clone,   610/610
(100 %)
5 diff
(99.2 %id)
AK308538 cerebellum .c 3624 to 5127 1 to 1504   tiling clone,   1504/1504
(100 %)
2 diff
(99.9 %id)
DC302940 cerebellum .c 3624 to 4182 1 to 559       559/559
(100 %)
1 diff
(99.9 %id)
AK307446 amygdala .c 3728 to 5254 1 to 1527   tiling clone,   1527/1527
(100 %)
2 diff
(99.9 %id)
DC313985 amygdala .c 3728 to 4218 1 to 491       491/491
(100 %)
0 diff
(100 %id)
BQ355325 head_neck .c 4981 to 5405 14 to 435       422/436
(96 %)
14 diff
(96.8 %id)
CB050332 Prostate .c 4990 to 5362 4 to 372   fully sequenced, Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 369/372
(99 %)
13 diff
(96.6 %id)
BG819133 anaplastic oligodendroglioma with 1p/19qloss, brain .c 5006 to 5664 1 to 651       651/653
(99 %)
13 diff
(98.1 %id)
TI_149314240   .c 5040 to 5824 852 to 83   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 770/924
(83 %)
49 diff
(94.7 %id)
TI_149300677   .c 5042 to 5832 826 to 53       774/1006
(76 %)
0 diff
(100 %id)
TI_149311673   .c 5050 to 5831 856 to 91   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 766/940
(81 %)
20 diff
(97.9 %id)
BG912339 anaplastic oligodendroglioma with 1p/19qloss, brain .c 5112 to 5824 1 to 710       710/726
(97 %)
10 diff
(98.7 %id)
BF529452 anaplastic oligodendroglioma with 1p/19qloss, brain .c 5117 to 5832 1 to 712   tiling clone,   712/863
(82 %)
6 diff
(99.4 %id)
BU620663 cell lines, Chondrosarcoma .c 5121 to 5831 723 to 19   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 705/707
(99 %)
7 diff
(99.1 %id)
BM976697 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 5127 to 5832 717 to 18       700/719
(97 %)
0 diff
(100 %id)
CB305922 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 5127 to 5824 711 to 19   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 693/697
(99 %)
4 diff
(99.5 %id)
TI_149290674   .c 5161 to 5824 747 to 87   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 661/962
(68 %)
31 diff
(96.8 %id)
BG477765 melanotic melanoma, skin .c 5172 to 5664 1 to 492       492/903
(54 %)
6 diff
(99.4 %id)
BQ015707 lung, Metastatic Chondrosarcoma .c 5172 to 5824 668 to 19   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 650/650
(100 %)
5 diff
(99.3 %id)
BC021270 Skin, melanotic melanoma. .c 5173 to 5664 10 to 501   tiling clone, AAA   492/825
(59 %)
5 diff
(99.4 %id)
BM977458 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 5173 to 5831 673 to 19   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 655/655
(100 %)
3 diff
(99.6 %id)
AA326980 lung .c 5241 to 5501 1 to 258       258/258
(100 %)
5 diff
(98.1 %id)
BQ015898 lung, Metastatic Chondrosarcoma .c 5241 to 5824 598 to 19   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 580/580
(100 %)
15 diff
(97.5 %id)
CA429188 Cell Line, Chondrosarcoma .c 5268 to 5824 572 to 19   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 554/554
(100 %)
7 diff
(98.8 %id)
BU948412 insulinoma, Pancreas .c 5273 to 5735 8 to 466       459/466
(98 %)
6 diff
(98.8 %id)
BM999190 lung, Lung Focal Fibrosis .c 5283 to 5825 557 to 19   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 539/539
(100 %)
3 diff
(99.5 %id)
CB050331 Prostate .c 5332 to 5824 524 to 32   fully sequenced, AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 493/493
(100 %)
0 diff
(100 %id)
BM973641 lung .c 5349 to 5824 494 to 19   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 476/476
(100 %)
5 diff
(99.0 %id)
AI627312 Kidney .c 5352 to 5832 481 to 2   tiling clone,   480/481
(99 %)
0 diff
(100 %id)
BF513998   .c 5352 to 5831 497 to 18   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 480/480
(100 %)
1 diff
(99.8 %id)
AI831981 B-cell, chronic lymphotic leukemia .c 5360 to 5831 473 to 1       473/473
(100 %)
1 diff
(99.8 %id)
AI769782 2 pooled tumors (clear cell type), Kidney .c 5362 to 5824 464 to 2       463/466
(99 %)
0 diff
(100 %id)
AW241561 pooled germ cell tumors .c 5368 to 5824 456 to 1       456/457
(99 %)
4 diff
(99.2 %id)
TI_154066539   .c 5370 to 5820 550 to 100   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 451/591
(76 %)
2 diff
(99.7 %id)
AW236440 pooled germ cell tumors .c 5373 to 5820 448 to 1       448/448
(100 %)
7 diff
(98.5 %id)
AI523768 B-cell, chronic lymphotic leukemia .c 5374 to 5824 462 to 12   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 451/451
(100 %)
0 diff
(100 %id)
AI655388 pooled germ cell tumors .c 5384 to 5824 462 to 22   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 441/441
(100 %)
1 diff
(99.8 %id)
AI392706 B-cell, chronic lymphotic leukemia .c 5385 to 5736 352 to 1       352/352
(100 %)
1 diff
(99.8 %id)
AA865764 germinal center B cell .c 5388 to 5831 486 to 46   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 441/441
(100 %)
5 diff
(98.9 %id)
AW237184 pooled germ cell tumors .c 5389 to 5824 448 to 13   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 436/436
(100 %)
3 diff
(99.4 %id)
BC011354 Brain, anaplastic oligodendroglioma with1p/19q loss .c 5389 to 5831 1 to 443   available from MGC, AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 443/443
(100 %)
0 diff
(100 %id)
BF347344 anaplastic oligodendroglioma with 1p/19qloss, brain .c 5389 to 5831 12 to 462   available from MGC, AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 451/462
(97 %)
6 diff
(98.8 %id)
BE326973 Kidney .c 5408 to 5824 419 to 3       417/419
(99 %)
0 diff
(100 %id)
AA207012 germinal center B cell .c 5409 to 5831 459 to 37   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 423/423
(100 %)
9 diff
(97.9 %id)
AI214175 astrocytoma, brain .c 5410 to 5795 386 to 1       386/386
(100 %)
0 diff
(100 %id)
AI470135 pooled .c 5410 to 5831 437 to 14   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 424/424
(100 %)
2 diff
(99.6 %id)
AA767180 germinal center B cell .c 5411 to 5824 420 to 10       411/420
(97 %)
0 diff
(100 %id)
AI660751 thymus, pooled .c 5411 to 5824 422 to 8       415/422
(98 %)
0 diff
(100 %id)
BF348368 anaplastic oligodendroglioma with 1p/19qloss, brain .c 5424 to 5824 1 to 426   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 426/426
(100 %)
30 diff
(93.0 %id)
AI090220 uterus .c 5432 to 5831 431 to 32   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 400/400
(100 %)
10 diff
(97.5 %id)
BE046437 colon, juvenile granulosa tumor .c 5432 to 5831 417 to 18   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 400/400
(100 %)
1 diff
(99.8 %id)
AI679610 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 5434 to 5831 424 to 27   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 398/398
(100 %)
2 diff
(99.5 %id)
AA721027 germinal center B cell .c 5442 to 5831 429 to 40   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 390/392
(99 %)
6 diff
(98.5 %id)
AA876121 germinal center B cell .c 5442 to 5824 438 to 56   AAA   383/414
(92 %)
0 diff
(100 %id)
AI027992 parathyroid gland, parathyroid tumor .c 5447 to 5832 386 to 1       386/386
(100 %)
1 diff
(99.8 %id)
AI354359 esophagus, squamous cell carcinoma .c 5447 to 5830 386 to 3       384/386
(99 %)
0 diff
(100 %id)
D50985   .c 5454 to 5831 378 to 1       378/378
(100 %)
1 diff
(99.8 %id)
R73523 breast .c 5460 to 5831 374 to 1       374/381
(98 %)
15 diff
(96.1 %id)
AI968966 brain, four pooled pituitary adenomas .c 5466 to 5831 382 to 17   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 366/366
(100 %)
1 diff
(99.8 %id)
AI921901 2 pooled tumors (clear cell type), Kidney .c 5475 to 5824 354 to 5       350/354
(98 %)
0 diff
(100 %id)
TI_151733626   .c 5475 to 5824 434 to 85   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 350/950
(36 %)
4 diff
(99.6 %id)
BQ188865.
matches multiple genes
eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 5482 to 5824 1 to 343   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base), also hits gene tuky 343/343
(100 %)
0 diff
(100 %id)
AI679862 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 5484 to 5824 371 to 31   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 341/341
(100 %)
8 diff
(97.7 %id)
AI758200.
matches multiple genes
Kidney .c 5520 to 5824 305 to 1     also hits gene tuky 305/305
(100 %)
0 diff
(100 %id)
AW615644 lung, small cell carcinoma .c 5524 to 5832 314 to 6       309/314
(98 %)
0 diff
(100 %id)
BF527341 anaplastic oligodendroglioma with 1p/19qloss, brain .c 5528 to 5832 18 to 322       305/348
(87 %)
3 diff
(99.2 %id)
AL041587 testis .c 5564 to 5824 1 to 261   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 261/261
(100 %)
0 diff
(100 %id)
AW451590   .c 5564 to 5824 278 to 18   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 261/271
(96 %)
0 diff
(100 %id)
AI277283 placenta .c 5569 to 5831 277 to 14   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 264/264
(100 %)
1 diff
(99.7 %id)
AI253201 Kidney .c 5569 to 5831 283 to 21   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 263/263
(100 %)
0 diff
(100 %id)
Z40581.
matches multiple genes
brain, total brain .c 5603 to 5824 222 to 1     also hits gene tuky 222/222
(100 %)
1 diff
(99.6 %id)
AA648323 germinal center B cell .c 5613 to 5831 261 to 43   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 219/219
(100 %)
0 diff
(100 %id)
BP393702.
matches multiple genes
pancreatic islet .c 5651 to 5821 1 to 172     Submitted on the opposite strand, also hits gene tuky 172/175
(98 %)
2 diff
(98.9 %id)
AW152037.
matches multiple genes
poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 5654 to 5824 171 to 1     also hits gene tuky 171/171
(100 %)
0 diff
(100 %id)
CA775002 Pancreas, Purified pancreatic islet .d-u 1 to 452 1 to 453   tiling clone, fully sequenced,   453/453
(100 %)
7 diff
(98.5 %id)
DB568939 hypothalamus .d-u 367 to 859 1 to 493     Submitted on the opposite strand 493/493
(100 %)
0 diff
(100 %id)
DB576160 hypothalamus .d-u 367 to 859 1 to 493     Submitted on the opposite strand 493/493
(100 %)
0 diff
(100 %id)
CA774752 Pancreas, Purified pancreatic islet .d-u 422 to 859 438 to 1   fully sequenced,   438/438
(100 %)
1 diff
(99.8 %id)
AW339592 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .d-u 443 to 860 418 to 1   tiling clone,   418/418
(100 %)
0 diff
(100 %id)
BX109640 lymph node, lymphoma, follicular mixed small and largecell .d-u 471 to 873 403 to 1   tiling clone,   403/403
(100 %)
0 diff
(100 %id)
AA767543 germinal center B cell .d-u 491 to 630 140 to 1       140/140
(100 %)
0 diff
(100 %id)
AI492757 lymph node, lymphoma, follicular mixed small and largecell .d-u 554 to 860 306 to 1       306/306
(100 %)
1 diff
(99.7 %id)
AA568133   .d-u 649 to 862 1 to 213       213/213
(100 %)
1 diff
(99.6 %id)
BI160653 epithelioid carcinoma cell line, Pancreas .e 1 to 666 9 to 674 P218A L219M tiling clone,   666/674
(98 %)
9 diff
(98.7 %id)
BG913434 anaplastic oligodendroglioma with 1p/19qloss, brain .e 2 to 516 12 to 538       527/538
(97 %)
25 diff
(95.4 %id)
CD580490 brain .f 1 to 913 1 to 914 C66F tiling clone,   914/926
(98 %)
30 diff
(96.8 %id)
CD580312 brain .g 1 to 712 1 to 710 exact tiling clone,   710/717
(99 %)
5 diff
(99.4 %id)
AK130532 salivary gland .h 1 to 1862 893 to 2758 exact tiling clone, available from FLJ,   1866/2758
(67 %)
31 diff
(98.9 %id)
AW842068 colon_normal .h 1392 to 2017 649 to 18       632/649
(97 %)
0 diff
(100 %id)
AW842078 colon_normal .h 1415 to 2023 632 to 17       616/654
(94 %)
0 diff
(100 %id)
AW842066 colon_normal .h 1417 to 2017 631 to 19       613/647
(94 %)
0 diff
(100 %id)
D29071   .h 1477 to 1861 19 to 398       380/398
(95 %)
5 diff
(98.8 %id)
DB497843 hypothalamus .h 1740 to 2235 1 to 498   tiling clone,   498/498
(100 %)
1 diff
(99.8 %id)
DB504900 hypothalamus .h 1740 to 2209 1 to 473   tiling clone,   473/473
(100 %)
1 diff
(99.8 %id)
BG910792 anaplastic oligodendroglioma with 1p/19qloss, brain .i 1 to 716 1 to 719   tiling clone,   719/720
(99 %)
11 diff
(98.5 %id)
DC316614 amygdala .i 614 to 1176 1 to 564   tiling clone,   564/564
(100 %)
3 diff
(99.5 %id)
BG674223 skin .j-u 1 to 877 1 to 892   tiling clone,   892/896
(99 %)
18 diff
(98.0 %id)
BM542104 melanotic melanoma, skin .j-u 48 to 584 19 to 556   tiling clone,   538/1176
(45 %)
15 diff
(98.8 %id)
AL534471 brain, fetal brain .j-u 111 to 1158 1 to 1040 F85I H86S F87S Q88W L89N ... tiling clone,   1040/1046
(99 %)
6 diff
(99.5 %id)
BM763202 myeloma .j-u 178 to 821 1 to 641       641/641
(100 %)
4 diff
(99.4 %id)
BM797177 Ascites, stomach .j-u 202 to 764 1 to 563       563/563
(100 %)
0 diff
(100 %id)
BM826330 Ascites, stomach .j-u 225 to 712 1 to 488       488/488
(100 %)
0 diff
(100 %id)
BF530477 anaplastic oligodendroglioma with 1p/19qloss, brain .j-u 263 to 994 1 to 722 F79S T80L P81L G82E V83F ... tiling clone,   722/794
(90 %)
6 diff
(99.3 %id)
BF531034 anaplastic oligodendroglioma with 1p/19qloss, brain .j-u 263 to 990 11 to 721 F79S T80L P81L G82E V83F ...     711/828
(85 %)
18 diff
(97.9 %id)
AA339062 brain .j-u 264 to 575 1 to 312       312/312
(100 %)
1 diff
(99.7 %id)
CD723792 eye, lacrimal gland .j-u 269 to 883 1 to 611       611/611
(100 %)
3 diff
(99.6 %id)
BP424262 small intestine .j-u 272 to 741 44 to 514     Submitted on the opposite strand 471/514
(91 %)
6 diff
(98.9 %id)
AA336915 endometrium .j-u 289 to 568 1 to 281       281/281
(100 %)
1 diff
(99.7 %id)
AW966201   .j-u 290 to 802 1 to 516   tiling clone,   516/518
(99 %)
18 diff
(96.6 %id)
BE304616 adenocarcinoma cell line, colon .j-u 299 to 970 1 to 663 F85I H86S F87S Q88W L89N ...     663/672
(98 %)
13 diff
(98.1 %id)
H83048 liver and spleen .j-u 321 to 672 1 to 355       355/355
(100 %)
7 diff
(98.1 %id)
AA324129 brain, cerebellum .k 1 to 336 1 to 336   tiling clone,   336/336
(100 %)
1 diff
(99.8 %id)
AW962010   .k 2 to 666 1 to 667 E140G tiling clone,   667/667
(100 %)
14 diff
(98.0 %id)
BQ881113 dorsal root ganglia .l-u 1 to 524 1 to 527 exact tiling clone,   527/977
(53 %)
8 diff
(99.2 %id)
BM827501 Ascites, stomach Gene HIP1R, variant not shown         Suspected internal deletion, this clone was ignored    
AV745735 Pituitary Gene HIP1R, variant not shown         Suspected internal deletion, this clone was ignored    
AV745738 Pituitary Gene HIP1R, variant not shown         Suspected internal deletion, this clone was ignored    
EC552535 Prostate Gene HIP1R, variant not shown         This clone was ignored    
AB209530 brain Gene HIP1R, variant not shown         Submitted on the opposite strand    
AV729034 hypothalamus Gene HIP1R, variant not shown         Suspected internal deletion, this clone was ignored    
BY799913 eye Gene HIP1R, variant not shown         Suspected internal deletion, this clone was ignored    
BG911778 anaplastic oligodendroglioma with 1p/19qloss, brain Gene HIP1R, variant not shown         Suspected internal deletion, this clone was ignored    
CB068322 Pancreas, Purified pancreatic islet Gene HIP1R, variant not shown         This clone was ignored    
CB177217 Pancreas, Purified pancreatic islet Gene HIP1R, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d-u, .e, .f, .g, .h, .i, .j-u, .k, .l-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI